u/ignacio_vanhecke

the GIP side does different things than the GLP-1 side, that is the point

This is the "correlation is mechanism" thing again. You changed three variables at once.

regulatory claims need a citation to the actual rule, not interpretation

Asked 13 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.

The telehealth + compounding combo cost 503A plus 19% markup. Not cheap but covered by insurance depending on state.

nope, the equivalence to semaglutide is not known, comparing 15mg tirz to 2.4mg sema is guessing

the reflux from tirz is different, not necessarily worse

The dual agonism story is real. The appetite is physically different from semaglutide alone.

What was the column and what gradient?

This is correct. PBS listings matter.

seizure and reship are different outcomes

do not suggest misrepresenting a diagnosis, that is fraud

Not to be pedantic but appeal and denial are being used interchangeably and they are not interchangeable in real life.

What was the denial code?

Which state? Rules vary.

Yeah, the 2024 rule change was sudden.

The confident tone is doing a lot of work that the evidence is not.

Strongly agree. Step therapy is predictable if you have the criteria.

AU and NZ are different systems, say which